Release Date: May 30, 2025
Expiration Date: May 30, 2026
Activity Overview
Nearly half the population older than 60 years has more than 1.0 diopter of keratometric astigmatism. With the emergence of more advanced intraocular lenses (IOLs) and surgical technologies, corneal astigmatism management has become an important treatment goal in modern cataract surgeries. In this program, expert faculty discuss opportunities for improved astigmatism management during cataract surgery by applying patient assessment, patients’ goals and preferences, and toric IOL choices.
This educational activity is an archive of the live virtual symposium held on April 26, 2025.
Target Audience
This educational curriculum is directed toward ophthalmologists, optometrists and other eyecare professionals involved in the treatment and management of cataract surgery.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Differentiate between available IOL products with respect to materials technology and design
- Identify patients with astigmatism who are appropriate candidates for IOL surgery
- Select appropriate IOLs based on patient presentation and goals of therapy
Tanner Ferguson, MD
Cornea, Glaucoma, Cataract, and Refractive Surgeon
Vance Thompson Vision
Sioux Falls, SD, and Sioux City, NE
Disclosures: Grant/Research Support: Alcon; Consultant: Balance Ophthalmics, RxSight; Shareholder: GreenMan; Other: equity: Balance Ophthalmics
Taj Nasser, MD, FWCRS
Refractive, Cataract, and Anterior Segment Surgeon
Medical Director
Tylock George Eye Care
Dallas, TX
Disclosures: Consultant: AbbVie, Alcon, Bausch + Lomb, LUMIBIRD, STAAR Surgical, Tarsus Pharmaceuticals
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource, LLC (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.